Spero Therapeutics, Inc. Operating Lease, Weighted Average Discount Rate, Percent
Spero Therapeutics, Inc. (SPRO) had Operating Lease, Weighted Average Discount Rate, Percent of 9.80% as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-03-26
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 9.80%.
- 2024-12-31: Operating Lease, Weighted Average Discount Rate, Percent 9.80%.
- 2023-12-31: Operating Lease, Weighted Average Discount Rate, Percent 9.80%.
- 2022-12-31: Operating Lease, Weighted Average Discount Rate, Percent 9.80%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent | Operating Lease, Weighted Average Discount Rate, Percent as first filed |
|---|---|---|
| 2025-12-31 | 9.80% 10-K · filed 2026-03-26 | |
| 2024-12-31 | 9.80% 10-K · filed 2026-03-26 | |
| 2023-12-31 | 9.80% 10-K · filed 2025-03-27 | |
| 2022-12-31 | 9.80% 10-K · filed 2024-03-13 | |
| 2021-12-31 | 9.80% 10-K · filed 2023-03-30 | |
| 2020-12-31 | 9.80% 10-K · filed 2022-03-31 | |
| 2020-09-30 | 9.80% 10-Q · filed 2020-11-05 | |
| 2020-06-30 | 9.80% 10-Q · filed 2020-08-06 | |
| 2020-03-31 | 10.30% 10-Q · filed 2020-05-08 | |
| 2019-12-31 | 10.30% 10-K · filed 2021-03-11 | 10.00% 10-K · filed 2020-03-16 |
| 2019-09-30 | 11.00% 10-Q · filed 2019-11-04 | |
| 2019-06-30 | 11.00% 10-Q · filed 2019-08-08 | |
| 2019-03-31 | 11.00% 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |